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to the beam direction. 
 
 
 
                                  
Conclusion 
We quantified dosimetric changes due to unplanned gas 
cavities in MRgRT using Monte Carlo dose calculations. 
Dose changes around the surface of unplanned spherical 
air cavities can be well characterised as a modulated 
sinusoidal function. The fit does deteriorate slightly in a 
consistent place around each cavity. Work is currently 
being done to extend the model beyond the cavity surface, 
create a generalised form for the relevant cavity 
diameters, and to implement the fit function into a 
simulation platform that takes multiple beam directions 
into account.  
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Purpose or Objective 
Radiation-induced lung toxicity (RILT) is a dose limiting 
complication of thoracic radiotherapy that impacts on the 
clinical benefits of dose escalation strategies in lung 
cancer. Lung dose volume parameters have a limited 
ability to identify patients at risk of RILT and recent 
studies suggest functional dosimetric parameters provide 
stronger predictive values than conventional anatomical 
parameters. The incorporation of regional ventilation 
information obtained via hyperpolarised gas MRI has been 
shown to reduce functional lung dose in conformal (3D-
CRT) and fixed-field intensity-modulated radiotherapy (ff-
IMRT) planning. Here we report the effects of 
hyperpolarised 3He MRI for volumetric modulated arc 
therapy (VMAT) in a cohort of lung cancer patients. 
Material and Methods 
Ten non-small cell lung cancer (NSCLC) patients being 
planned for radical radiotherapy underwent inspiratory 
breath-hold CT and same-breath anatomical 1H MRI and 
hyperpolarized 3He MRI ventilation at the same inflation 
state as CT. The ventilated lung was segmented using a 
fuzzy c-means clustering algorithm. Binary ventilation 
maps were registered to breath-hold CT via its same-
breath anatomical 1H MRI. VMAT plans with two partial 
arcs that minimised dose to the anatomical lung volume 
were compared with plans that minimised dose to the 3He 
defined functional lung volume. For each pair of plans, the 
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20Gy (fV20), mean functional lung dose (fMLD) and 
percentage of planning target volume (PTV) receiving 95% 
of the prescription dose (PTV95) were compared. 
Results 
Incorporation of 3He MRI ventilation information led to 
statistically significant median reductions in fV10 of 1.3% 
(range: -0.12.4%; p=0.016) and fV20 of 0.8% (range: -0.2
1.1%; p=0.007). A small but significant reduction in fMLD 
of 0.3Gy (range: 0.10.4 Gy; p=0.005) was also observed. 
There was no difference in target coverage: median 
difference in PTV95 of 0.0% (range: -0.20.1%; p=0.447). 
Patients with the largest individual reductions in fV10 and 
fV20 demonstrated large functional defects either in close 
proximity to the target volume or at the periphery of the 
ipsilateral lung. Significant negative correlation between 
the percentage of ventilated ipsilateral lung and both fV10 
and fV20 was also observed (Rs = -0.707, p = 0.022 and Rs = 
-0.665, p = 0.036 respectively). 
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Conclusion 
Functionally-guided VMAT plans incorporating regional 
ventilation information from hyperpolarised 3He MRI can 
permit dosimetric reduction to the ventilated lung volume 
without compromising PTV coverage. The degree of 
reduction is however less than that previously reported for 
3D-CRT and ff-IMRT planning, which may be attributable 
to increased dose conformity with VMAT. The location of 
ventilation defect in relation to target volume is an 
important factor in reducing function lung dose, with the 
greatest reduction possible in patients with significant 
ventilation defects located in the ipsilateral lung. 
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Purpose or Objective 
An advantage of coplanar VMAT in SBRT is short delivery 
time. It also avoids long planning times related to 
optimization of non-coplanar beam arrangements, and 
most commercial TPSs lack advanced options for beam 
angle optimization (BAO). On the other hand, optimized 
non-coplanar setups can often significantly improve SBRT 
dose distributions. In this study we used automated 
planning with integrated BAO to explore advantages of 
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aiming at plan quality improvement relative to VMAT while 
limiting the increase in treatment time. The analyses 
resulted in a proposal for a two-beam noncoplanar class 
solution to supplement VMAT. 
Material and Methods 
For 20 prostate SBRT patients with a prescribed dose of 38 
Gy in 4 fractions, our platform for fully automated multi-
criterial treatment planning was first used to generate 
dual-arc VMAT plans supplemented with five non-coplanar 
IMRT beams with optimized patient-specific beam 
orientations (VMAT+5). Next, based on the selected non-
coplanar beam directions in the patient group (20x5 beams 
in total), two preferred non-coplanar beam directions 
were selected as class solution (CS), and for each of the 
20 patients a VMAT+CS plan was automatically generated. 
The VMAT+CS plans were benchmarked against a) dual-arc 
coplanar VMAT plans, b) the VMAT+5 plans, and c) IMRT 
plans with 30 computer-optimized non-coplanar beams 
(30NCP). For comparison, all plans were normalized to 
have identical PTV coverage. Deliverability of generated 
plans was verified with QA measurements by executing 
plans at the linac, where treatment delivery times were 
also measured. 
Results 
Fig. 1 shows treatment plan parameters for the four 
treatment approaches normalized to the values of VMAT. 
Overall the quality of VMAT+CS plans is similar to VMAT+5, 
while optimization times were reduced by a factor of 25 
due to the omission of BAO. Compared to VMAT, VMAT+CS 
significantly reduced doses to rectum and bladder and 
dose bath, showing median percentage differences from 
1-24% for rectum D1cc, Dmean, V40GyEq, and V60GyEq, bladder 
Dmean, and patient VxGy (all p<0.001, Fig. 1). All VMAT and 
VMAT+CS plans passed the dosimetric QA tests (3%/1 mm 
criteria) with average Gamma passing rates of 98.3±1.0% 
and 98.3±0.7%, respectively. Compared to VMAT, 
VMAT+CS plans required 3% less MU on average and only 
1.9±0.7 min longer total delivery time. Compared to 
30NCP, VMAT+CS plans were considered clinically 
equivalent with respect to high doses in the rectum and 
bladder (Fig. 1A) and much faster to deliver, while 30NCP 
had more favorable low dose bath (Fig. 1B). 
 
 
 
Conclusion 
Using an algorithm for fully automated multi-criterial 
beam profile and beam angle optimization (BAO), we 
derived a two-beam non-coplanar class solution (CS) to 
supplement VMAT for prostate SBRT. Adding the CS beams 
to a coplanar VMAT plan resulted in substantial 
improvements in treatment plan quality with a minimal 
increase in treatment time. The fixed CS avoids the need 
for patient-specific BAO. 
